2025-01-16 19:10:44
PharmAbcine to Participate in H.C. Wainright 23rd Annual Global Investment Conference
Corporate/ 2023-07-23
PharmAbcine to Participate in H.C. Wainr...

DAEJEON,South Korea,Aug. 23,2021-- PharmAbcine Inc. (KOSDAQ: 208340ks),a clinical-stage biotech company focusing on the development of next ...

RedHill Biopharma Announces Two New U.S. Patents Covering Opaganib for Ebola Virus and RHB-104 for Crohn's
Corporate/ 2023-07-23
RedHill Biopharma Announces Two New U.S....

U.S. patents for opaganib combination for the treatment of Ebola virus disease provides patent protection until 2035

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release